Skip to main content

Form 8.3 – [APTITUDE SOFTWARE GROUP PLC – 07 09 2026] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree APTITUDE SOFTWARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: APTITUDE...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 07 09 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Star Bulk Carriers Corp. Announcement Offering Price Range for the Equity Offering in Greece

IMPORTANT NOTICE – DISCLAIMER Not for release or distribution or publication in whole or in part, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa. These materials do not contain or constitute an offer for sale or the solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan or the Republic of South Africa. The securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act“), and may not be offered or sold in the United States or to U.S. persons absent such registration, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. No offering of securities is being made in the United States or to U.S. persons. ATHENS,...

Continue reading

Atos to develop a new digital service model for Barcelona City Council employees

Press Release Atos to develop a new digital service model for Barcelona City Council employees The company will collaborate with the Municipal Institute of Innovation and Technology of Barcelona to offer more agile and efficient technological support, incorporating new automation, self-service and artificial intelligence capabilities to improve the experience of municipal employees Barcelona and Paris, September 8, 2026 – Atos, a global leader in digital transformation powered by Artificial Intelligence, has been selected by the Municipal Institute of Innovation and Technology, the entity responsible for leading the digital transformation of Barcelona City Council, to collaborate in the evolution of the technological services used daily by thousands of municipal professionals. The project aims to move towards a more agile, accessible...

Continue reading

Himax Unveils Industry-Leading eDP TDDI, Advancing Automotive Display Technology

Single-Chip Solution Integrates High-Speed eDP Interface, Touch, and Display Driver For Large-Format, High-Resolution Smart Car Displays TAINAN, Taiwan, Sept. 08, 2026 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or the “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced the unveiling of the industry-leading automotive TDDI (Touch and Display Driver Integration) with high-speed eDP interface support, the HX83196/HX83197 series. The new solution integrates a high-speed eDP interface, touch, and display driver into a single chip, addressing the demands of next-generation smart car displays for large-format, high-resolution, high-quality displays and responsive touch performance. Himax’s new eDP TDDI adopts the latest eSRE (eDP Stream Regeneration...

Continue reading

Investeringsforeningen Carnegie Wealth Management – Forløb af ekstraordinær generalforsamling

Investeringsforeningen Carnegie Wealth Management har dags dato afholdt ekstraordinær generalforsamling. Generalforsamlingen blev gennemført i overensstemmelse med den fremlagte dagsorden og vedtægterne. Bestyrelsens forslag om at ændre foreningens navn fra Investeringsforeningen Carnegie Wealth Management til Investeringsforeningen DNB Carnegie Wealth Management blev vedtaget. De forelagte forslag til vedtægtsændringer blev således godkendt af generalforsamlingen. Vedtægtsændringerne, herunder foreningens navneændring, er herefter betinget af Finanstilsynets godkendelse. Eventuelle henvendelser vedrørende denne meddelelse bedes rettet til tlf. 38 14 66 00. Med venlig hilsenInvest Administration A/S Niels Erik EberhardDirektør

Continue reading

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

– Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma – – Verekitug also delivered clinically meaningful improvements in lung function (FEV1) and exhaled nitric oxide (FeNO) with every 12-week dosing – – The Company remains on track to initiate Phase 3 trials in severe asthma and CRSwNP in Q1 2027, designed to deliver best-in-class efficacy in both indications by evaluating a 400 mg quarterly regimen of verekitug in broad patient populations – WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for severe inflammatory respiratory diseases, today presented results from the Phase 2 VALIANT clinical trial evaluating the safety and efficacy of verekitug in adults with severe asthma in a late-breaking...

Continue reading

Rubis: Availability of the 2026 half-year financial report

Paris, 8 September 2026, 9.00am Rubis announces today that its half-year financial report as of 30 June 2026 is available and has been filed with the Autorité des Marchés Financiers (the French Financial Markets Authority – AMF). The 2026 half-year financial report can be downloaded from Rubis’ website (www.rubis.fr), in the “Investors – Regulated information – Half-year financial report” section.    This document is a translation of the original French document and is provided for information purposes only. In all matters of interpretation of information, views or opinions expressed therein, the original French version takes precedence over this translation  Contact  RUBIS – Legal Department  Tel: +(33) 1 44 17 95 95AttachmentRubis: Availability of the 2026 half-year financial report

Continue reading

INSIDE INFORMATION: Martela is planning a directed share issue of EUR 5–8 million and the combination of its share series

Martela Corporation, Inside information, 8 September 2026 at 9:30 a.m. (EEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Martela Corporation (“Martela” or the “Company”) is planning a directed share issue against consideration to raise gross proceeds of EUR 5–8 million (the “Share Issue”). The objective of the Share Issue is to strengthen the Company’s working capital and secure the continuity of its business, support the development of its business, rehabilitate its capital structure and broaden its shareholder base. The Company is also planning to combine its existing share...

Continue reading

LEADING EDGE MATERIALS DRILLS NEAR-MINE TO TEST FOR A LARGER REGIONAL GRAPHITE SYSTEM AT WOXNA, SWEDEN

NEWS RELEASE                                    September 7, 2026 LEADING EDGE MATERIALS DRILLS NEAR-MINE TO TEST FOR A LARGER REGIONAL GRAPHITE SYSTEM AT WOXNA, SWEDENDrilling to test whether the Kringeltjärn, Råttjärnamyren and Svartboberget graphite occurrences at Woxna are part of one connected, regional graphite-bearing system. Historical drilling identified a thick graphite-bearing sequence at depth at Svartboberget, while historical data point to potential continuity toward Råttjärnamyren and Kringeltjärn. Positive results would provide strong justification for a larger follow-up drilling campaign and could add to the resource growth potential at Woxna, one of the few fully built and permitted natural flake graphite mines in Europe.Vancouver, September 7, 2026 – Leading Edge Materials Corp. (“Leading Edge Materials”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.